Skip to main content

Peer Review reports

From: Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study

Original Submission
21 Oct 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 Dec 2011 Reviewed Reviewer Report - Dora Pascual-Salcedo
Resubmission - Version 3
Submitted Manuscript version 3
9 Mar 2012 Author responded Author comments - Aatke van der Maas
3 Feb 2012 Reviewed Reviewer Report - Hector Chinoy
Resubmission - Version 4
9 Mar 2012 Submitted Manuscript version 4
17 May 2012 Author responded Author comments - Aatke van der Maas
27 Mar 2012 Reviewed Reviewer Report - Dora Pascual-Salcedo
28 Mar 2012 Reviewed Reviewer Report - Hector Chinoy
Resubmission - Version 5
17 May 2012 Submitted Manuscript version 5
13 Jul 2012 Author responded Author comments - Aatke van der Maas
Resubmission - Version 6
13 Jul 2012 Submitted Manuscript version 6
Publishing
19 Sep 2012 Editorially accepted
24 Sep 2012 Article published 10.1186/1471-2474-13-184

You can find further information about peer review here.

Back to article page
\